Dr Paula Gonzalez-Figueroa has been awarded the Elizabeth Greene Industry Development Award to help fund her drug development project at the Centre for Personalised Immunology (CPI).
Philanthropist Peter Yates AM and his family established this program in honour of his half-sister Elizabeth Greene, who died from lupus.
JCSMR Academic, Professor Carola Vinuesa, Recognised as One of the World’s Most Influential Researchers.
Professor Carola Vinuesa at The Australian National University (ANU) has joined a prestigious list of Highly Cited Researchers awarded by the Web of Science.
The highly anticipated list identifies science and social science researchers who produced multiple papers ranking in the top one per cent by citations for their field, demonstrating significant research influence.
New Insights into Immune Function: Changing Our Understanding of B Cell Biology
In Memory of Alan Harvey
$10 million bequest to tackle rare autoimmune disease
Treatment for a rare and currently incurable autoimmune disease has been given a major boost thanks to a $10 million bequest made to The Australian National University (ANU).
The $10 million comes from Jenny and Bruce Pryor, who both passed away in 2017, and is the largest bequest the University has ever received.
The money will establish the Jenny and Bruce Pryor Research Fellowship at the ANU Centre for Personalised Immunology and be used to research dermatomyositis - which Jenny suffered from in her later years.
Groundbreaking genetic discovery shows why Lupus develops
In a world first, researchers from The Australian National University (ANU) have shown previously ignored rare genetic mutations are a major cause of lupus.
The discovery is set to change our understanding of the causes of disease and potentially save lives.
Lupus is an autoimmune disease that has no cure. It targets the body's healthy tissue, causing inflammation, damage and pain.
ANU welcomes government investment in phenomics research
The Australian National University (ANU) welcomed the Australian Government's announcement today of $10 million investment in the Translational Phenomics Initiative to advance critical understanding of disease mechanisms and validate approaches to new therapies.
JCSMR researchers identify new disease
Researchers at JCSMR have discovered a new genetic disease and a method for detecting more unexplained medical conditions.
"We've discovered a new syndrome, the genetic cause and the mechanism that explains how the genetic variation causes the illness," said Professor Matthew Cook from The ANU College of Health and Medicine.
ANU to lead new era of personalised medicine
ANU will strengthen its role as a leading centre for personalised medicine following the announcement of $7.3 million in funding from the ACT Government to set up a new centre, Canberra Clinical Genomics.
Canberra Clinical Genomics will be a partnership between ANU and ACT Health and will work to cure patients with complex diseases by sequencing their genome and finding treatments that are personalised to their condition.